Frontotemporal Lobar Degeneration Case with an N-Terminal <i>TUBA4A</i> Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology
Evelien Van Schoor,
Mathieu Vandenbulcke,
Valérie Bercier,
Rik Vandenberghe,
Julie van der Zee,
Christine Van Broeckhoven,
Markus Otto,
Bernard Hanseeuw,
Philip Van Damme,
Ludo Van Den Bosch,
Dietmar Rudolf Thal
Affiliations
Evelien Van Schoor
Laboratory of Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), 3000 Leuven, Belgium
Mathieu Vandenbulcke
Department of Geriatric Psychiatry, University Hospitals Leuven, 3000 Leuven, Belgium
Valérie Bercier
Laboratory of Neurobiology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), 3000 Leuven, Belgium
Rik Vandenberghe
Laboratory of Cognitive Neurology, Department of Neurosciences, KU Leuven (University of Leuven), 3000 Leuven, Belgium
Julie van der Zee
Neurodegenerative Brain Diseases, Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium
Christine Van Broeckhoven
Neurodegenerative Brain Diseases, Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium
Markus Otto
Department of Neurology, Ulm University, 89081 Ulm, Germany
Bernard Hanseeuw
UC Louvain and Department of Neurology, Institute of Neurosciences, University Hospital Saint-Luc, 1200 Brussels, Belgium
Philip Van Damme
Laboratory of Neurobiology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), 3000 Leuven, Belgium
Ludo Van Den Bosch
Laboratory of Neurobiology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), 3000 Leuven, Belgium
Dietmar Rudolf Thal
Laboratory of Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), 3000 Leuven, Belgium
Recently, disease-associated variants of the TUBA4A gene were identified in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here, we present the neuropathological report of a patient with the semantic variant of primary progressive aphasia with a family history of Parkinsonism, harboring a novel frameshift mutation c.187del (p.Arg64Glyfs*90) in TUBA4A. Immunohistochemistry showed abundant TAR DNA-binding protein 43 kDa (TDP-43) dystrophic neurite pathology in the frontal and temporal cortex and the dentate gyrus of the hippocampus, consistent with frontotemporal lobar degeneration (FTLD). The observed pathology pattern fitted best with that of FTLD-TDP Type C. qPCR showed the presence of mutant TUBA4A mRNA. However, no truncated TUBA4A was detected at the protein level. A decrease in total TUBA4A mRNA and protein levels suggests loss-of-function as a potential pathogenic mechanism. This report strengthens the idea that N-terminal TUBA4A mutations are associated with FTLD-TDP. These N-terminal mutations possibly exert their pathogenic effects through haploinsufficiency, contrary to C-terminal TUBA4A mutations which are thought to disturb the microtubule network via a dominant-negative mechanism.